International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Recurrent Hyperparathyroidis Revealing Parathyromatosis : a Case Report
| Author(s) | Dr. Zineb Serhane, Dr. Widad Moussaoui, Prof. Dr. El Azime Zineb, Prof. Dr. Essafi Mohammed Amine, Prof. Dr. Aynaou Hayat, Prof. Dr. Salhi Houda |
|---|---|
| Country | Morocco |
| Abstract | Introduction: Parathyromatosis is an extremely rare cause of recurrent or persistent primary hyperparathyroidism (PHPT), usually resulting from intraoperative seeding of parathyroid tissue following capsular rupture drecurruring surgery. Its diagnosis is difficult and may mimic parathyroid carcinoma. Case Report: We report the case of a 50-year-old woman with recurrent PHPT after three parathyroid surgeries. The first operation in 2012 for a right inferior parathyroid adenoma achieved temporary remission. Two further recurrences occurred in 2017 and 2022, each treated surgically, but postoperative hypercalcemia and elevated parathyroid hormone (PTH) persisted. Cervical ultrasound and 18F-fluorocholine PET/CT revealed multiple small hypermetabolic nodules scattered in the right neck region, consistent with secondary parathyromatosis. Given the patient’s refusal of further surgery, medical treatment with the calcimimetic cinacalcet was initiated, allowing long-term biochemical control at a dose of 120 mg/day. Conclusion: Parathyromatosis should be considered in any patient with multiple recurrences of PHPT after parathyroidectomy. High-performance imaging, especially 18F-fluorocholine PET/CT, is essential for localization. Careful handling of parathyroid glands during surgery is crucial to prevent this rare but challenging complication. While surgery remains the treatment of choice, cinacalcet can represent an effective alternative for non-surgical candidates. |
| Keywords | Parathyromatosis, Recurrent hyperparathyroidism, Persistent hyperparathyroidism, 18F-fluorocholine PET/CT, Parathyroid carcinoma, Cinacalcet, Calcimimetic, Parathyroid surgery |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-12-13 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.63276 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals